Kyasanur Forest Disease Virus: Epidemiological Insights, Pathogenesis, Therapeutic Strategies, and Advances in Vaccines and Diagnostics
Open Access
Abstract
Kyasanur Forest disease virus (KFDV), a tick-borne Orthoflavivirus endemic to the Indian subcontinent, is a public health threat due to its recurrent outbreaks and expanding geographic range. This review provides a comprehensive overview of KFDV, encompassing its epidemiological trends, transmission dynamics, and ecological determinants that influence its spread. We delve into the current understanding of KFDV pathogenesis, highlighting key viral and host factors that drive infection and disease progression. Despite the absence of targeted antiviral therapies, recent advances have spurred the development of candidate therapeutics, including broad-spectrum antivirals and immunomodulators. We also discuss progress in vaccine development, with an emphasis on the limitations of the existing formalin-inactivated vaccine and the promise of next-generation platforms. Furthermore, we explore recent innovations in diagnostics, including molecular and serological tools, that aim to improve early detection and surveillance. A multidisciplinary approach integrating virology, immunology, ecology, and public health is essential for the effective management and eventual control of KFDV outbreaks.Keywords
All Related Versions
Funding Information
- CSIR—Central Drug Research Institute (CDRI)
This publication has 74 references indexed in Scilit:
- Kyasanur Forest Disease: Clinical manifestations and molecular dynamics in a zoonotic landscapeClinical Infection in Practice, 2024
- Kyasanur Forest disease virus NS3 helicase: Insights into structure, activity, and inhibitorsInternational Journal of Biological Macromolecules, 2023
- Development and application of a recombinant Envelope Domain III protein based indirect human IgM ELISA for Kyasanur forest disease virusActa Tropica, 2022
- Point of care real-time polymerase chain reaction-based diagnostic for Kyasanur forest diseaseInternational Journal of Infectious Diseases, 2021
- Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virusAntiviral Research, 2018
- In vitro antiviral activity of adenosine analog NITD008 against tick-borne flavivirusesAntiviral Research, 2016
- Sofosbuvir: A Review of its Use in Patients with Chronic Hepatitis CDrugs, 2014
- Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodentsAntiviral Research, 2008
- Tick-borne flaviviruses: dissecting host immune responses and virus countermeasuresImmunologic Research, 2008
- Kyasanur forest disease: an epidemiological view in IndiaReviews in Medical Virology, 2006